1. Akhondzadeh, S., Naghavi, H. R., Vazirian, M., Shayeganpour, A., Rashidi, H., & Khani, M. (2001). Passionflower in the treatment of generalized anxiety: A pilot double‐blind randomized controlled trial with oxazepam. Journal of clinical pharmacy and therapeutics, 26(5), 363-367. [Reference Link]

2. Richardson, N. (2020). Your Period Handbook: Natural Solutions for Stress Free Menstruation. Karnac Books. [Reference Link]

3. Dorantes-Barrón, A.M., et al. (2019). Neurobehavioral and toxicological effects of an aqueous extract of Turnera diffusa Willd (Turneraceae) in mice. Journal of Ethnopharmacology, 236, 50–62. https://doi.org/10.1016/j.jep.2019.02.036. [Reference Link]

4. Kumar, S., Madaan, R., & Sharma, A. (2008). Estimation of apigenin, an anxiolytic constituent, Inturnera Aphrodisiaca. Indian Journal of Pharmaceutical Sciences, 70(6), 847. https://doi.org/10.4103/0250-474x.49143. [Reference Link]

5. Hongratanaworakit, T. (2009). Relaxing effect of rose oil on humans. Natural Product Communications, 4(2), 1934578X0900400226. [Reference Link]

6. Wood, M. (1997) The book of herbal wisdom: using plants as medicines. North Atlantic Books. [Reference Link]

7. Boskabady M.H., Shafei M.N., Saberi Z., & Amini S. (2011). Pharmacological effects of rosa damascena. Iran J Basic Med Sci. 14(4):295-307. PMID: 23493250; PMCID: PMC3586833. [Reference Link]

8. Adams, J. D., Garcia, C., & Garg, G. (2012). Mugwort (Artemisia vulgaris, Artemisia douglasiana, Artemisia argyi) in the treatment of menopause, premenstrual syndrome, dysmenorrhea and attention deficit hyperactivity disorder. Chinese Medicine, 2012, 3, 116-123. http://dx.doi.org/10.4236/cm.2012.33019. [Reference Link]

9. Rebello, C. J., Keller, J. N., Liu, A. G., Johnson, W. D., & Greenway, F. L. (2015). Pilot feasibility and safety study examining the effect of medium chain triglyceride supplementation in subjects with mild cognitive impairment: A randomized controlled trial. BBA Clinical, 3, 123–125. https://doi.org/10.1016/j.bbacli.2015.01.001. [Reference Link]

10. Skelley, J. W., Deas, C. M., Curren, Z., & Ennis, J. (2020). Use of cannabidiol in anxiety and anxiety-related disorders. Journal of the American Pharmacists Association, 60(1), 253–261. https://doi.org/10.1016/j.japh.2019.11.008. [Reference Link]

11. Cascio, M. G., Gauson, L. A., Stevenson, L. A., Ross, R. A., & Pertwee, R. G. (2009). Evidence that the plant cannabinoid cannabigerol is a highly potent α2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist. British Journal of Pharmacology, 159(1), 129–141. https://doi.org/10.1111/j.1476-5381.2009.00515.x. [Reference Link]